043 - Combating Chronic Vertigo: Interview with Sam Owen and Didier Depireux of Otolith Labs

Otolith Labs is pioneering the first medical wearable for the treatment of vertigo, a symptom experienced by more than 15 million Americans. Company CEO, Samuel Owen, and Chief Science Officer, Dr. Didier Depireux, join host Bob Traynor for a discussion of their promising new wearable technology under development for patients with vertigo.   The novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers. Otolith hopes to have FDA approval of their device by late 2023.   Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:  https://www.linkedin.com/company/this-week-in-hearing/  https://twitter.com/WeekinHearing